Predicting Herb-disease Associations Through Graph Convolutional Network

被引:4
作者
Hu, Xuan [1 ,2 ]
Lu, You [3 ]
Tian, Geng [2 ,4 ]
Bing, Pingping [5 ,6 ]
Wang, Bing [1 ]
He, Binsheng [5 ,6 ]
机构
[1] Anhui Univ Technol, Sch Elect & Informat Engn, Maanshan 243002, Anhui, Peoples R China
[2] Geneis Beijing Co Ltd, Beijing 100102, Peoples R China
[3] Emergency Gen Hosp, Dept Pharm, Beijing 100028, Peoples R China
[4] Qingdao Geneis Inst Big Data Min & Precis Med, Qingdao 266000, Peoples R China
[5] Changsha Med Univ, Academician Workstat, Changsha 410219, Peoples R China
[6] Changsha Med Univ, Sch Pharm, Changsha 410219, Peoples R China
关键词
Herb-disease associations; TCM-Suit database; graph convolutional network; attention mechanism; drug repositioning; AUPRC; PANAX-GINSENG; PROTOCATECHUIC ACID; GANODERMA-LUCIDUM; MATRIX COMPLETION; RANDOM-WALK; DRUG; PHARMACOLOGY; ANTICANCER; TARGETS;
D O I
10.2174/1574893618666230504143647
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background In recent years, herbs have become very popular worldwide as a form of complementary and alternative medicine (CAM). However, there are many types of herbs and diseases, whose associations are impossible to be fully revealed. Identifying new therapeutic indications of herbs, that is drug repositioning, is a critical supplement for new drug development. Considering that exploring the associations between herbs and diseases by wet-lab techniques is time-consuming and laborious, there is an urgent need for reliable computational methods to fill this gap. In this study, we first preprocessed the herbs and their indications in the TCM-Suit database, a comprehensive, accurate, and integrated traditional Chinese medicine database, to obtain the herb-disease association network. We then proposed a novel model based on a graph convolution network (GCN) to infer potential new associations between herbs and diseases.Background In recent years, herbs have become very popular worldwide as a form of complementary and alternative medicine (CAM). However, there are many types of herbs and diseases, whose associations are impossible to be fully revealed. Identifying new therapeutic indications of herbs, that is drug repositioning, is a critical supplement for new drug development. Considering that exploring the associations between herbs and diseases by wet-lab techniques is time-consuming and laborious, there is an urgent need for reliable computational methods to fill this gap. In this study, we first preprocessed the herbs and their indications in the TCM-Suit database, a comprehensive, accurate, and integrated traditional Chinese medicine database, to obtain the herb-disease association network. We then proposed a novel model based on a graph convolution network (GCN) to infer potential new associations between herbs and diseases.Methods In our method, the effective features of herbs and diseases were extracted through multi-layer GCN, then the layer attention mechanism was introduced to combine the features learned from multiple GCN layers, and jump connections were added to reduce the over-smoothing phenomenon caused by multi-layer GCN stacking. Finally, the recovered herb-disease association network was generated by the bilinear decoder. We applied our model together with four other methods (including SCMFDD, BNNR, LRMCMDA, and DRHGCN) to predict herb-disease associations. Compared with all other methods, our model showed the highest area under the receiver operating characteristic curve (AUROC), the area under the precision-recall curve (AUPRC), as well as the highest recall in the five-fold cross-validation.Conclusion We further used our model to predict the candidate herbs for Alzheimer's disease and found the compounds mediating herbs and diseases through the herb-compound-gene-disease network. The relevant literature also confirmed our findings.
引用
收藏
页码:610 / 619
页数:10
相关论文
共 83 条
  • [1] [Anonymous], 2013, WHO Traditional Medicine Strategy 20142023
  • [2] Ginseng pharmacology - Multiple constituents and multiple actions
    Attele, AS
    Wu, JA
    Yuan, CS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) : 1685 - 1693
  • [3] Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6
  • [4] Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
    Boh, Bojana
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2013, 8 (03) : 255 - 287
  • [5] Drug repositioning based on the heterogeneous information fusion graph convolutional network
    Cai, Lijun
    Lu, Changcheng
    Xu, Junlin
    Meng, Yajie
    Wang, Peng
    Fu, Xiangzheng
    Zeng, Xiangxiang
    Su, Yansen
    [J]. BRIEFINGS IN BIOINFORMATICS, 2021, 22 (06)
  • [6] Ginseng Extracts Restore High-Glucose Induced Vascular Dysfunctions by Altering Triglyceride Metabolism and Downregulation of Atherosclerosis-Related Genes
    Chan, Gabriel Hoi-huen
    Law, Betty Yuen-kwan
    Chu, John Man-tak
    Yue, Kevin Kin-man
    Jiang, Zhi-hong
    Lau, Chi-wai
    Huang, Yu
    Chan, Shun-wan
    Yue, Patrick Ying-kit
    Wong, Ricky Ngok-shun
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [7] Chaudhari V., 2018, J Appl Pharmaceut Sci and Res, V1, P19
  • [8] Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis
    Chen, Sichao
    Liu, Zeming
    Li, Man
    Huang, Yihui
    Wang, Min
    Wang, Wen
    Wei, Wei
    Zhang, Chao
    Gong, Yan
    Guo, Liang
    [J]. CURRENT GENE THERAPY, 2020, 20 (01) : 5 - 14
  • [9] Drug-target interaction prediction by random walk on the heterogeneous network
    Chen, Xing
    Liu, Ming-Xi
    Yan, Gui-Ying
    [J]. MOLECULAR BIOSYSTEMS, 2012, 8 (07) : 1970 - 1978
  • [10] Network-based approach to prediction and population-based validation of in silico drug repurposing
    Cheng, Feixiong
    Desai, Rishi J.
    Handy, Diane E.
    Wang, Ruisheng
    Schneeweiss, Sebastian
    Barabasi, Albert-Laszlo
    Loscalzo, Joseph
    [J]. NATURE COMMUNICATIONS, 2018, 9